Senseonics to Participate in the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE American: SENS), specializing in long-term, implantable continuous glucose monitoring systems, plans to participate in the virtual H.C. Wainwright Global Investment Conference. Management will engage in one-on-one meetings on September 15, 2021, with a presentation webcast available starting September 13, 2021, at 7:00 AM ET. Access to the on-demand webcast will be provided on the company’s website. Senseonics is dedicated to transforming diabetes management with its Eversense® CGM products, which offer real-time glucose data via a mobile app.

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming virtual H.C. Wainwright Global Investment Conference.

Management is scheduled to participate and hold one on-one-meetings Wednesday, September 15, 2021. A presentation webcast will be available at the start of the conference on Monday, September 13, 2021, at 7:00am ET. Interested parties may access the on-demand webcast at the same time on the “Investors” section of the Company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909006192/en/

Senseonics Investor Relations Contact:

Lynn Lewis or Philip Taylor

Investor Relations

415-937-5406

Investors@senseonics.com

Source: Senseonics Holdings, Inc.

FAQ

When is Senseonics participating in the H.C. Wainwright Global Investment Conference?

Senseonics will participate in the H.C. Wainwright Global Investment Conference on September 15, 2021.

What time will Senseonics' presentation webcast be available?

The presentation webcast from Senseonics will be available starting at 7:00 AM ET on September 13, 2021.

How can I access the Senseonics conference webcast?

The Senseonics conference webcast can be accessed on the company's website in the 'Investors' section.

What products does Senseonics focus on?

Senseonics focuses on the development of long-term implantable continuous glucose monitoring systems, specifically the Eversense® CGM products.

What is the ticker symbol for Senseonics?

The ticker symbol for Senseonics is SENS.